eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes.
Gao L, Ramirez FJ, Cabrera JTO, Varghese MV, Watanabe M, Tsuji-Hosokawa A, Zheng Q, Yang M, Razan MR, Kempf CL, Camp SM, Wang J, Garcia JGN, Makino A.
Gao L, et al. Among authors: watanabe m.
Diabetologia. 2024 Jun 19. doi: 10.1007/s00125-024-06201-9. Online ahead of print.
Diabetologia. 2024.
PMID: 38898303